Committees

Executive Committee

The Blanton-Davis Ovarian Cancer Research Program Executive Committee is comprised of leading physicians and researchers at M. D. Anderson Cancer Center who are working to eradicate ovarian cancer:

Karen Basen-Engquist, Ph.D.
Assistant Professor, Department of Behavioral Science

Robert C. Bast, Jr., M.D.
Vice President, Translational Research

Diane C. Bodurka, M.D.
Associate Professor, Department of Gynecologic Oncology

Robert L. Coleman, M.D.
Associate Professor, Department of Gynecologic Oncology

Ms. Catherine Ellison
Patient Advocate

David M. Gershenson, M.D.
Professor and Chairman, Department of Gynecologic Oncology

John J. Kavanagh, M.D.
Professor and Chief, Section of Gynecologic Medical Therapeutics

Gabriel Lopez-Berestein, M.D.
Professor, Internist, Department of Experimental Therapeutics

Karen H. Lu, M.D.
Associate Professor, Department of Gynecologic Oncology

Gordon B. Mills, M.D., Ph.D
Professor and Chairman, Department of Molecular Therapeutics

Ms. Kim Podraza
Patient Advocate

Anil K. Sood, M.D.
Co-Director, Blanton-Davis Ovarian Cancer Research Program
Professor, Department of Gynecologic Oncology

Mr. Stephen Stuyck
Vice President, Public Affairs

J. Taylor Wharton, M.D.
Special Assistant to the President
Professor, Department of Gynecologic Oncology

Judith K. Wolf, M.D.
Co-Director, Blanton-Davis Ovarian Cancer Research Program
Associate Professor, Department of Gynecologic Oncology

Mrs. Kenna Wood
Patient Advocate

Advisory Board

The Advisory Board of the Blanton-Davis Ovarian Cancer Research Program is comprised of prominent individuals, many of whom have been touched by ovarian cancer in their own lives, who are dedicated to helping us with our mission of eradicating this disease.

These committee members are invaluable as they serve as advisors to the Program as well as ambassadors in the community to help educate women about the risk factors and symptoms of ovarian cancer.